RT Journal Article SR Electronic T1 Fluorescent Antibody-Based Detection and Ultrastructural Analysis of Streptococcus pneumoniae in Human Sputum JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.10.22.24314814 DO 10.1101/2024.10.22.24314814 A1 Jop Vidal, Ana G. A1 Francis, Meg A1 Chitanvis, Maneesha A1 Frame, Ithiel J. A1 Sharma, Poonam A1 Vidal, Patricio A1 Lanata, Claudio F. A1 Grijalva, Carlos A1 Daley, William A1 Vidal, Jorge E. YR 2024 UL http://medrxiv.org/content/early/2024/10/23/2024.10.22.24314814.abstract AB Background Pneumococcal pneumonia continues to be a significant global health burden, affecting both children and adults. Traditional diagnostic methods for sputum analysis remain challenging. The objective of this study was twofold: to develop a rapid and easy-to-perform assay for the identification of Streptococcus pneumoniae (Spn) directly in sputum specimens using fluorescence microscopy, and to characterize with high-resolution confocal microscopy the ultrastructure of pneumococci residing in human sputum.Methods We fluorescently labeled antibodies against the pneumococcal capsule (Spn-FLUO). The specificity and sensitivity of Spn-FLUO for detecting Spn was evaluated in vitro and in vivo using mouse models of carriage and disease, human nasopharyngeal specimens, and sputum from patients with pneumococcal pneumonia. Spn was confirmed in the specimens using culture and a species-specific qPCR assays. Confocal microscopy and Imaris software analysis were utilized to resolve the ultrastructure of pneumococci in human sputum.Results Compared with cultures and qPCR, Spn-FLUO demonstrated high sensitivity (78-96%) in nasopharyngeal samples from mice and humans. The limit of detection (LOD) in nasopharyngeal samples was ≥1.6×10⁴ GenEq/ml. The specificity in human nasopharyngeal specimens was 100%. In lung specimens from mice infected with pneumococci, Spn-FLUO reached 100% sensitivity with a LOD of ≥1.39×10⁴ GenEq/ml. In human sputum, the sensitivity for detecting Spn was 92.7% with a LOD of 3.6×10³ GenEq/ml. Ultrastructural studies revealed that pneumococci are expectorated as large aggregates with a median size of 1336 µm².Conclusions Spn-FLUO is a rapid and sensitive assay for detecting Spn in human sputum within 30 min. The study highlights that most pneumococci form aggregates in human sputum.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported in part by a grant from the National Institutes of Health (NIH; 5R21AI144571-03, R01AI173084-03 and 1R01AI175461-01A1) and by a grant from NIGMS through the Molecular Center of Health and Disease (1P20GM144041-01A1 7651). Studies of confocal microscopy, and histology, were supported by grants from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health under Award Numbers P20GM121334 and P20GM104357. The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board (IRB) of the University of Mississippi Medical Center (Federalwide Assurance FWA#00003630) waived ethical approval of this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscriptSpnStreptococcus pneumoniaeSpn-FLUOFluorescent antibodies against the pneumococcal capsuleqPCRQuantitative polymerase chain reactionLODLimit of DetectionGenEq/mlGenome equivalents/milliliterµm2Square micrometerminMinutesCAPCommunity-acquired pneumoniaCO2Carbon dioxideO2OxygenhHours(m)PCRMultiplex polymerase chain reactionCFUColony Forming UnitsCFU/gColony forming units/gramWGAWheat Germ AgglutininGlcNAcN-acetyl-D-glucosamineSASialic acidBAPBlood agar platesTHYTodd Hewitt broth containing yeast extractStrStreptomycinTmpTrimethoprimTetTetracyclineEryErythromycinµg/mlMicrogram/milliliterPBSPhosphate Buffered SalineMEMMinimum Essential MediumFBSFetal Bovine SerumPFAParaformaldehydeBSABovine Serum AlbuminµMMicromoleIACUCInstitutional Animal Care and Use CommitteeAWANational Science Foundation Animal Welfare ActIRBInstitutional Review BoardUMMCUniversity of Mississippi Medical CenterWHOWorld Health OrganizationNPNasopharyngealµlMicroliterng/ µlNanogram/microliterMbMegabasesSeconds